146 related articles for article (PubMed ID: 26946361)
1. Improving the reproducibility of the NAP1/B1/027 epidemic strain R20291 in the hamster model of infection.
Kelly ML; Ng YK; Cartman ST; Collery MM; Cockayne A; Minton NP
Anaerobe; 2016 Jun; 39():51-3. PubMed ID: 26946361
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin.
Kuehne SA; Dempster AW; Collery MM; Joshi N; Jowett J; Kelly ML; Cave R; Longshaw CM; Minton NP
J Antimicrob Chemother; 2018 Apr; 73(4):973-980. PubMed ID: 29253242
[TBL] [Abstract][Full Text] [Related]
3. Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile.
Nagaro KJ; Phillips ST; Cheknis AK; Sambol SP; Zukowski WE; Johnson S; Gerding DN
Antimicrob Agents Chemother; 2013 Nov; 57(11):5266-70. PubMed ID: 23939887
[TBL] [Abstract][Full Text] [Related]
4. The role of flagella in Clostridium difficile pathogenesis: comparison between a non-epidemic and an epidemic strain.
Baban ST; Kuehne SA; Barketi-Klai A; Cartman ST; Kelly ML; Hardie KR; Kansau I; Collignon A; Minton NP
PLoS One; 2013; 8(9):e73026. PubMed ID: 24086268
[TBL] [Abstract][Full Text] [Related]
5. Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains.
Denève C; Bouttier S; Dupuy B; Barbut F; Collignon A; Janoir C
Antimicrob Agents Chemother; 2009 Dec; 53(12):5155-62. PubMed ID: 19805572
[TBL] [Abstract][Full Text] [Related]
6. Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain.
Skinner AM; Petrella L; Siddiqui F; Sambol SP; Gulvik CA; Gerding DN; Donskey CJ; Johnson S
Emerg Infect Dis; 2020 Feb; 26(2):247-254. PubMed ID: 31961290
[TBL] [Abstract][Full Text] [Related]
7. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1.
Akerlund T; Persson I; Unemo M; Norén T; Svenungsson B; Wullt M; Burman LG
J Clin Microbiol; 2008 Apr; 46(4):1530-3. PubMed ID: 18287318
[TBL] [Abstract][Full Text] [Related]
8. The flagellin FliC of Clostridium difficile is responsible for pleiotropic gene regulation during in vivo infection.
Barketi-Klai A; Monot M; Hoys S; Lambert-Bordes S; Kuehne SA; Minton N; Collignon A; Dupuy B; Kansau I
PLoS One; 2014; 9(5):e96876. PubMed ID: 24841151
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activities of the novel Ketolide RBx 14255 against Clostridium difficile.
Kumar M; Mathur T; Barman TK; Ramkumar G; Bhati A; Shukla G; Kalia V; Pandya M; Raj VS; Upadhyay DJ; Vaishnavi C; Chakrabarti A; Das B; Bhatnagar PK
Antimicrob Agents Chemother; 2012 Nov; 56(11):5986-9. PubMed ID: 22869573
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027.
Wieczorkiewicz JT; Lopansri BK; Cheknis A; Osmolski JR; Hecht DW; Gerding DN; Johnson S
Antimicrob Agents Chemother; 2016 Jan; 60(1):418-23. PubMed ID: 26525793
[TBL] [Abstract][Full Text] [Related]
11. In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.
Carman RJ; Boone JH; Grover H; Wickham KN; Chen L
Antimicrob Agents Chemother; 2012 Nov; 56(11):6019-20. PubMed ID: 22908175
[TBL] [Abstract][Full Text] [Related]
12. Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden.
Norén T; Tang-Feldman YJ; Cohen SH; Silva J; Olcén P
Diagn Microbiol Infect Dis; 2002 Feb; 42(2):149-51. PubMed ID: 11858913
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary analysis of a nontoxigenic Clostridium difficile strain with stable resistance to metronidazole.
Moura I; Monot M; Tani C; Spigaglia P; Barbanti F; Norais N; Dupuy B; Bouza E; Mastrantonio P
Antimicrob Agents Chemother; 2014 Aug; 58(8):4957-60. PubMed ID: 24913157
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to antibiotics of Clostridium difficile toxigenic nosocomial strains.
Beran V; Chmelar D; Vobejdova J; Konigova A; Nemec J; Tvrdik J
Folia Microbiol (Praha); 2014 May; 59(3):209-15. PubMed ID: 24114414
[TBL] [Abstract][Full Text] [Related]
15. Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile.
Duvall JR; Bedard L; Naylor-Olsen AM; Manson AL; Bittker JA; Sun W; Fitzgerald ME; He Z; Lee MD; Marie JC; Muncipinto G; Rush D; Xu D; Xu H; Zhang M; Earl AM; Palmer MA; Foley MA; Vacca JP; Scherer CA
ACS Infect Dis; 2017 May; 3(5):349-359. PubMed ID: 28215073
[TBL] [Abstract][Full Text] [Related]
16. In vivo selection of moxifloxacin-resistant Clostridium difficile.
Mena A; Riera E; López-Causapé C; Weber I; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2012 May; 56(5):2788-9. PubMed ID: 22371889
[No Abstract] [Full Text] [Related]
17. Mechanism of action of and mechanism of reduced susceptibility to the novel anti-Clostridium difficile compound LFF571.
Leeds JA; Sachdeva M; Mullin S; Dzink-Fox J; Lamarche MJ
Antimicrob Agents Chemother; 2012 Aug; 56(8):4463-5. PubMed ID: 22644023
[TBL] [Abstract][Full Text] [Related]
18. Tetracycline resistance gene tet(W) in the pathogenic bacterium Clostridium difficile.
Spigaglia P; Barbanti F; Mastrantonio P
Antimicrob Agents Chemother; 2008 Feb; 52(2):770-3. PubMed ID: 18070963
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of toxigenic Clostridium difficile in a northern Italian hospital.
De Rosa FG; Cavallerio P; Corcione S; Parlato C; Fossati L; Serra R; Di Perri G; Cavallo R
Curr Microbiol; 2015 Feb; 70(2):154-5. PubMed ID: 25245958
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone resistance and Clostridium difficile, Germany.
Zaiss NH; Witte W; Nübel U
Emerg Infect Dis; 2010 Apr; 16(4):675-7. PubMed ID: 20350385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
